{"id":26892,"date":"2026-03-19T14:36:46","date_gmt":"2026-03-19T18:36:46","guid":{"rendered":"https:\/\/www.cryoport.com\/?p=26892"},"modified":"2026-04-23T16:34:11","modified_gmt":"2026-04-23T20:34:11","slug":"atc-2026-keynote-recap-building-global-readiness-for-advanced-therapies","status":"publish","type":"post","link":"https:\/\/www.cryoport.com\/fr\/atc-2026-keynote-recap-building-global-readiness-for-advanced-therapies\/","title":{"rendered":"R\u00e9capitulation de la conf\u00e9rence ATC 2026 : Renforcer la pr\u00e9paration mondiale aux th\u00e9rapies innovantes"},"content":{"rendered":"","protected":false},"excerpt":{"rendered":"<p>Alison Pritchard, vice-pr\u00e9sidente du d\u00e9veloppement commercial &#8211; EMEA chez Cryoport Systems, a prononc\u00e9 le discours d&rsquo;ouverture du Congr\u00e8s 2026 sur les th\u00e9rapies avanc\u00e9es, ancrant la discussion dans le rythme acc\u00e9l\u00e9r\u00e9 de l&rsquo;expansion mondiale de l&rsquo;industrie des th\u00e9rapies cellulaires et g\u00e9niques. Les essais cliniques s&rsquo;\u00e9tendent d\u00e9sormais couramment sur plusieurs r\u00e9gions et les r\u00e9seaux de fabrication sont r\u00e9partis de telle sorte qu&rsquo;ils n\u00e9cessitent une coordination constante. Ces mod\u00e8les sont devenus la norme plut\u00f4t que l&rsquo;exception. Comme elle l&rsquo;a d\u00e9crit, l&rsquo;environnement op\u00e9rationnel des th\u00e9rapies avanc\u00e9es est d\u00e9j\u00e0 devenu mondial, et chaque programme est cens\u00e9 fonctionner dans cette r\u00e9alit\u00e9 bien plus t\u00f4t que par le pass\u00e9.     <\/p>\n","protected":false},"author":38,"featured_media":26898,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"single-with-related.php","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[593],"tags":[213,246,623,601],"class_list":["post-26892","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-apercu-de-lindustrie","tag-biostockage","tag-cryoconservation","tag-essais-cliniques","tag-gestion-de-la-chaine-dapprovisionnement-mondiale"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.6 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>R\u00e9capitulation de la conf\u00e9rence ATC 2026 : Renforcer la pr\u00e9paration mondiale aux th\u00e9rapies innovantes - Cryoport Systems<\/title>\n<meta name=\"description\" content=\"Alison Pritchard, vice-pr\u00e9sidente du d\u00e9veloppement commercial - EMEA chez Cryoport Systems, a prononc\u00e9 le discours d&#039;ouverture du Congr\u00e8s 2026 sur les th\u00e9rapies avanc\u00e9es, ancrant la discussion dans le rythme acc\u00e9l\u00e9r\u00e9 de l&#039;expansion mondiale de l&#039;industrie des th\u00e9rapies cellulaires et g\u00e9niques. Les essais cliniques s&#039;\u00e9tendent d\u00e9sormais couramment sur plusieurs r\u00e9gions et les r\u00e9seaux de fabrication sont r\u00e9partis de telle sorte qu&#039;ils n\u00e9cessitent une coordination constante. Ces sch\u00e9mas sont devenus la norme plut\u00f4t que l&#039;exception. Comme elle l&#039;a d\u00e9crit, l&#039;environnement op\u00e9rationnel des th\u00e9rapies avanc\u00e9es est d\u00e9j\u00e0 devenu mondial, et chaque programme est cens\u00e9 fonctionner dans cette r\u00e9alit\u00e9 bien plus t\u00f4t que par le pass\u00e9.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.cryoport.com\/fr\/atc-2026-keynote-recap-building-global-readiness-for-advanced-therapies\/\" \/>\n<meta property=\"og:locale\" content=\"fr_FR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"R\u00e9capitulation de la conf\u00e9rence ATC 2026 : Renforcer la pr\u00e9paration mondiale aux th\u00e9rapies innovantes - Cryoport Systems\" \/>\n<meta property=\"og:description\" content=\"Alison Pritchard, vice-pr\u00e9sidente du d\u00e9veloppement commercial - EMEA chez Cryoport Systems, a prononc\u00e9 le discours d&#039;ouverture du Congr\u00e8s 2026 sur les th\u00e9rapies avanc\u00e9es, ancrant la discussion dans le rythme acc\u00e9l\u00e9r\u00e9 de l&#039;expansion mondiale de l&#039;industrie des th\u00e9rapies cellulaires et g\u00e9niques. Les essais cliniques s&#039;\u00e9tendent d\u00e9sormais couramment sur plusieurs r\u00e9gions et les r\u00e9seaux de fabrication sont r\u00e9partis de telle sorte qu&#039;ils n\u00e9cessitent une coordination constante. Ces sch\u00e9mas sont devenus la norme plut\u00f4t que l&#039;exception. Comme elle l&#039;a d\u00e9crit, l&#039;environnement op\u00e9rationnel des th\u00e9rapies avanc\u00e9es est d\u00e9j\u00e0 devenu mondial, et chaque programme est cens\u00e9 fonctionner dans cette r\u00e9alit\u00e9 bien plus t\u00f4t que par le pass\u00e9.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.cryoport.com\/fr\/atc-2026-keynote-recap-building-global-readiness-for-advanced-therapies\/\" \/>\n<meta property=\"og:site_name\" content=\"Cryoport Systems\" \/>\n<meta property=\"article:published_time\" content=\"2026-03-19T18:36:46+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2026-04-23T20:34:11+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.cryoport.com\/wp-content\/uploads\/2026\/03\/Advanced-Therapies-Keynote-Blue.png\" \/>\n\t<meta property=\"og:image:width\" content=\"1200\" \/>\n\t<meta property=\"og:image:height\" content=\"628\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"smendez\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@cryoport\" \/>\n<meta name=\"twitter:site\" content=\"@cryoport\" \/>\n<meta name=\"twitter:label1\" content=\"\u00c9crit par\" \/>\n\t<meta name=\"twitter:data1\" content=\"smendez\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.cryoport.com\\\/fr\\\/atc-2026-keynote-recap-building-global-readiness-for-advanced-therapies\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.cryoport.com\\\/fr\\\/atc-2026-keynote-recap-building-global-readiness-for-advanced-therapies\\\/\"},\"author\":{\"name\":\"smendez\",\"@id\":\"https:\\\/\\\/www.cryoport.com\\\/fr\\\/#\\\/schema\\\/person\\\/41e3344a83f354e30051a36b4e0a5f86\"},\"headline\":\"R\u00e9capitulation de la conf\u00e9rence ATC 2026 : Renforcer la pr\u00e9paration mondiale aux th\u00e9rapies innovantes\",\"datePublished\":\"2026-03-19T18:36:46+00:00\",\"dateModified\":\"2026-04-23T20:34:11+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.cryoport.com\\\/fr\\\/atc-2026-keynote-recap-building-global-readiness-for-advanced-therapies\\\/\"},\"wordCount\":16,\"publisher\":{\"@id\":\"https:\\\/\\\/www.cryoport.com\\\/fr\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/www.cryoport.com\\\/fr\\\/atc-2026-keynote-recap-building-global-readiness-for-advanced-therapies\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.cryoport.com\\\/wp-content\\\/uploads\\\/2026\\\/03\\\/Advanced-Therapies-Keynote-Blue.png\",\"keywords\":[\"biostockage\",\"Cryoconservation\",\"Essais cliniques\",\"Gestion de la cha\u00eene d'approvisionnement mondiale\"],\"articleSection\":[\"Aper\u00e7u de l'industrie\"],\"inLanguage\":\"fr-FR\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.cryoport.com\\\/fr\\\/atc-2026-keynote-recap-building-global-readiness-for-advanced-therapies\\\/\",\"url\":\"https:\\\/\\\/www.cryoport.com\\\/fr\\\/atc-2026-keynote-recap-building-global-readiness-for-advanced-therapies\\\/\",\"name\":\"R\u00e9capitulation de la conf\u00e9rence ATC 2026 : Renforcer la pr\u00e9paration mondiale aux th\u00e9rapies innovantes - Cryoport Systems\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.cryoport.com\\\/fr\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.cryoport.com\\\/fr\\\/atc-2026-keynote-recap-building-global-readiness-for-advanced-therapies\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.cryoport.com\\\/fr\\\/atc-2026-keynote-recap-building-global-readiness-for-advanced-therapies\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.cryoport.com\\\/wp-content\\\/uploads\\\/2026\\\/03\\\/Advanced-Therapies-Keynote-Blue.png\",\"datePublished\":\"2026-03-19T18:36:46+00:00\",\"dateModified\":\"2026-04-23T20:34:11+00:00\",\"description\":\"Alison Pritchard, vice-pr\u00e9sidente du d\u00e9veloppement commercial - EMEA chez Cryoport Systems, a prononc\u00e9 le discours d'ouverture du Congr\u00e8s 2026 sur les th\u00e9rapies avanc\u00e9es, ancrant la discussion dans le rythme acc\u00e9l\u00e9r\u00e9 de l'expansion mondiale de l'industrie des th\u00e9rapies cellulaires et g\u00e9niques. Les essais cliniques s'\u00e9tendent d\u00e9sormais couramment sur plusieurs r\u00e9gions et les r\u00e9seaux de fabrication sont r\u00e9partis de telle sorte qu'ils n\u00e9cessitent une coordination constante. Ces sch\u00e9mas sont devenus la norme plut\u00f4t que l'exception. Comme elle l'a d\u00e9crit, l'environnement op\u00e9rationnel des th\u00e9rapies avanc\u00e9es est d\u00e9j\u00e0 devenu mondial, et chaque programme est cens\u00e9 fonctionner dans cette r\u00e9alit\u00e9 bien plus t\u00f4t que par le pass\u00e9.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.cryoport.com\\\/fr\\\/atc-2026-keynote-recap-building-global-readiness-for-advanced-therapies\\\/#breadcrumb\"},\"inLanguage\":\"fr-FR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.cryoport.com\\\/fr\\\/atc-2026-keynote-recap-building-global-readiness-for-advanced-therapies\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\\\/\\\/www.cryoport.com\\\/fr\\\/atc-2026-keynote-recap-building-global-readiness-for-advanced-therapies\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.cryoport.com\\\/wp-content\\\/uploads\\\/2026\\\/03\\\/Advanced-Therapies-Keynote-Blue.png\",\"contentUrl\":\"https:\\\/\\\/www.cryoport.com\\\/wp-content\\\/uploads\\\/2026\\\/03\\\/Advanced-Therapies-Keynote-Blue.png\",\"width\":1200,\"height\":628},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.cryoport.com\\\/fr\\\/atc-2026-keynote-recap-building-global-readiness-for-advanced-therapies\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.cryoport.com\\\/fr\\\/homepage\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"R\u00e9capitulation de la conf\u00e9rence ATC 2026 : Renforcer la pr\u00e9paration mondiale aux th\u00e9rapies innovantes\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.cryoport.com\\\/fr\\\/#website\",\"url\":\"https:\\\/\\\/www.cryoport.com\\\/fr\\\/\",\"name\":\"Cryoport Systems\",\"description\":\"Enabling the Future of Medicine\",\"publisher\":{\"@id\":\"https:\\\/\\\/www.cryoport.com\\\/fr\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.cryoport.com\\\/fr\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"fr-FR\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/www.cryoport.com\\\/fr\\\/#organization\",\"name\":\"Cryoport Systems\",\"url\":\"https:\\\/\\\/www.cryoport.com\\\/fr\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\\\/\\\/www.cryoport.com\\\/fr\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/www.cryoport.com\\\/wp-content\\\/uploads\\\/2023\\\/12\\\/systems-square.png\",\"contentUrl\":\"https:\\\/\\\/www.cryoport.com\\\/wp-content\\\/uploads\\\/2023\\\/12\\\/systems-square.png\",\"width\":1200,\"height\":1200,\"caption\":\"Cryoport Systems\"},\"image\":{\"@id\":\"https:\\\/\\\/www.cryoport.com\\\/fr\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/x.com\\\/cryoport\",\"https:\\\/\\\/www.linkedin.com\\\/company\\\/856887\",\"https:\\\/\\\/www.youtube.com\\\/user\\\/CryoportVideo\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.cryoport.com\\\/fr\\\/#\\\/schema\\\/person\\\/41e3344a83f354e30051a36b4e0a5f86\",\"name\":\"smendez\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/3ce9d56659c228959822d42e6e9146f3170fc590e93aa3adda9bb496df111835?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/3ce9d56659c228959822d42e6e9146f3170fc590e93aa3adda9bb496df111835?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/3ce9d56659c228959822d42e6e9146f3170fc590e93aa3adda9bb496df111835?s=96&d=mm&r=g\",\"caption\":\"smendez\"}}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"R\u00e9capitulation de la conf\u00e9rence ATC 2026 : Renforcer la pr\u00e9paration mondiale aux th\u00e9rapies innovantes - Cryoport Systems","description":"Alison Pritchard, vice-pr\u00e9sidente du d\u00e9veloppement commercial - EMEA chez Cryoport Systems, a prononc\u00e9 le discours d'ouverture du Congr\u00e8s 2026 sur les th\u00e9rapies avanc\u00e9es, ancrant la discussion dans le rythme acc\u00e9l\u00e9r\u00e9 de l'expansion mondiale de l'industrie des th\u00e9rapies cellulaires et g\u00e9niques. Les essais cliniques s'\u00e9tendent d\u00e9sormais couramment sur plusieurs r\u00e9gions et les r\u00e9seaux de fabrication sont r\u00e9partis de telle sorte qu'ils n\u00e9cessitent une coordination constante. Ces sch\u00e9mas sont devenus la norme plut\u00f4t que l'exception. Comme elle l'a d\u00e9crit, l'environnement op\u00e9rationnel des th\u00e9rapies avanc\u00e9es est d\u00e9j\u00e0 devenu mondial, et chaque programme est cens\u00e9 fonctionner dans cette r\u00e9alit\u00e9 bien plus t\u00f4t que par le pass\u00e9.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.cryoport.com\/fr\/atc-2026-keynote-recap-building-global-readiness-for-advanced-therapies\/","og_locale":"fr_FR","og_type":"article","og_title":"R\u00e9capitulation de la conf\u00e9rence ATC 2026 : Renforcer la pr\u00e9paration mondiale aux th\u00e9rapies innovantes - Cryoport Systems","og_description":"Alison Pritchard, vice-pr\u00e9sidente du d\u00e9veloppement commercial - EMEA chez Cryoport Systems, a prononc\u00e9 le discours d'ouverture du Congr\u00e8s 2026 sur les th\u00e9rapies avanc\u00e9es, ancrant la discussion dans le rythme acc\u00e9l\u00e9r\u00e9 de l'expansion mondiale de l'industrie des th\u00e9rapies cellulaires et g\u00e9niques. Les essais cliniques s'\u00e9tendent d\u00e9sormais couramment sur plusieurs r\u00e9gions et les r\u00e9seaux de fabrication sont r\u00e9partis de telle sorte qu'ils n\u00e9cessitent une coordination constante. Ces sch\u00e9mas sont devenus la norme plut\u00f4t que l'exception. Comme elle l'a d\u00e9crit, l'environnement op\u00e9rationnel des th\u00e9rapies avanc\u00e9es est d\u00e9j\u00e0 devenu mondial, et chaque programme est cens\u00e9 fonctionner dans cette r\u00e9alit\u00e9 bien plus t\u00f4t que par le pass\u00e9.","og_url":"https:\/\/www.cryoport.com\/fr\/atc-2026-keynote-recap-building-global-readiness-for-advanced-therapies\/","og_site_name":"Cryoport Systems","article_published_time":"2026-03-19T18:36:46+00:00","article_modified_time":"2026-04-23T20:34:11+00:00","og_image":[{"width":1200,"height":628,"url":"https:\/\/www.cryoport.com\/wp-content\/uploads\/2026\/03\/Advanced-Therapies-Keynote-Blue.png","type":"image\/png"}],"author":"smendez","twitter_card":"summary_large_image","twitter_creator":"@cryoport","twitter_site":"@cryoport","twitter_misc":{"\u00c9crit par":"smendez"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.cryoport.com\/fr\/atc-2026-keynote-recap-building-global-readiness-for-advanced-therapies\/#article","isPartOf":{"@id":"https:\/\/www.cryoport.com\/fr\/atc-2026-keynote-recap-building-global-readiness-for-advanced-therapies\/"},"author":{"name":"smendez","@id":"https:\/\/www.cryoport.com\/fr\/#\/schema\/person\/41e3344a83f354e30051a36b4e0a5f86"},"headline":"R\u00e9capitulation de la conf\u00e9rence ATC 2026 : Renforcer la pr\u00e9paration mondiale aux th\u00e9rapies innovantes","datePublished":"2026-03-19T18:36:46+00:00","dateModified":"2026-04-23T20:34:11+00:00","mainEntityOfPage":{"@id":"https:\/\/www.cryoport.com\/fr\/atc-2026-keynote-recap-building-global-readiness-for-advanced-therapies\/"},"wordCount":16,"publisher":{"@id":"https:\/\/www.cryoport.com\/fr\/#organization"},"image":{"@id":"https:\/\/www.cryoport.com\/fr\/atc-2026-keynote-recap-building-global-readiness-for-advanced-therapies\/#primaryimage"},"thumbnailUrl":"https:\/\/www.cryoport.com\/wp-content\/uploads\/2026\/03\/Advanced-Therapies-Keynote-Blue.png","keywords":["biostockage","Cryoconservation","Essais cliniques","Gestion de la cha\u00eene d'approvisionnement mondiale"],"articleSection":["Aper\u00e7u de l'industrie"],"inLanguage":"fr-FR"},{"@type":"WebPage","@id":"https:\/\/www.cryoport.com\/fr\/atc-2026-keynote-recap-building-global-readiness-for-advanced-therapies\/","url":"https:\/\/www.cryoport.com\/fr\/atc-2026-keynote-recap-building-global-readiness-for-advanced-therapies\/","name":"R\u00e9capitulation de la conf\u00e9rence ATC 2026 : Renforcer la pr\u00e9paration mondiale aux th\u00e9rapies innovantes - Cryoport Systems","isPartOf":{"@id":"https:\/\/www.cryoport.com\/fr\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.cryoport.com\/fr\/atc-2026-keynote-recap-building-global-readiness-for-advanced-therapies\/#primaryimage"},"image":{"@id":"https:\/\/www.cryoport.com\/fr\/atc-2026-keynote-recap-building-global-readiness-for-advanced-therapies\/#primaryimage"},"thumbnailUrl":"https:\/\/www.cryoport.com\/wp-content\/uploads\/2026\/03\/Advanced-Therapies-Keynote-Blue.png","datePublished":"2026-03-19T18:36:46+00:00","dateModified":"2026-04-23T20:34:11+00:00","description":"Alison Pritchard, vice-pr\u00e9sidente du d\u00e9veloppement commercial - EMEA chez Cryoport Systems, a prononc\u00e9 le discours d'ouverture du Congr\u00e8s 2026 sur les th\u00e9rapies avanc\u00e9es, ancrant la discussion dans le rythme acc\u00e9l\u00e9r\u00e9 de l'expansion mondiale de l'industrie des th\u00e9rapies cellulaires et g\u00e9niques. Les essais cliniques s'\u00e9tendent d\u00e9sormais couramment sur plusieurs r\u00e9gions et les r\u00e9seaux de fabrication sont r\u00e9partis de telle sorte qu'ils n\u00e9cessitent une coordination constante. Ces sch\u00e9mas sont devenus la norme plut\u00f4t que l'exception. Comme elle l'a d\u00e9crit, l'environnement op\u00e9rationnel des th\u00e9rapies avanc\u00e9es est d\u00e9j\u00e0 devenu mondial, et chaque programme est cens\u00e9 fonctionner dans cette r\u00e9alit\u00e9 bien plus t\u00f4t que par le pass\u00e9.","breadcrumb":{"@id":"https:\/\/www.cryoport.com\/fr\/atc-2026-keynote-recap-building-global-readiness-for-advanced-therapies\/#breadcrumb"},"inLanguage":"fr-FR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.cryoport.com\/fr\/atc-2026-keynote-recap-building-global-readiness-for-advanced-therapies\/"]}]},{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/www.cryoport.com\/fr\/atc-2026-keynote-recap-building-global-readiness-for-advanced-therapies\/#primaryimage","url":"https:\/\/www.cryoport.com\/wp-content\/uploads\/2026\/03\/Advanced-Therapies-Keynote-Blue.png","contentUrl":"https:\/\/www.cryoport.com\/wp-content\/uploads\/2026\/03\/Advanced-Therapies-Keynote-Blue.png","width":1200,"height":628},{"@type":"BreadcrumbList","@id":"https:\/\/www.cryoport.com\/fr\/atc-2026-keynote-recap-building-global-readiness-for-advanced-therapies\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.cryoport.com\/fr\/homepage\/"},{"@type":"ListItem","position":2,"name":"R\u00e9capitulation de la conf\u00e9rence ATC 2026 : Renforcer la pr\u00e9paration mondiale aux th\u00e9rapies innovantes"}]},{"@type":"WebSite","@id":"https:\/\/www.cryoport.com\/fr\/#website","url":"https:\/\/www.cryoport.com\/fr\/","name":"Cryoport Systems","description":"Enabling the Future of Medicine","publisher":{"@id":"https:\/\/www.cryoport.com\/fr\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.cryoport.com\/fr\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"fr-FR"},{"@type":"Organization","@id":"https:\/\/www.cryoport.com\/fr\/#organization","name":"Cryoport Systems","url":"https:\/\/www.cryoport.com\/fr\/","logo":{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/www.cryoport.com\/fr\/#\/schema\/logo\/image\/","url":"https:\/\/www.cryoport.com\/wp-content\/uploads\/2023\/12\/systems-square.png","contentUrl":"https:\/\/www.cryoport.com\/wp-content\/uploads\/2023\/12\/systems-square.png","width":1200,"height":1200,"caption":"Cryoport Systems"},"image":{"@id":"https:\/\/www.cryoport.com\/fr\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/x.com\/cryoport","https:\/\/www.linkedin.com\/company\/856887","https:\/\/www.youtube.com\/user\/CryoportVideo"]},{"@type":"Person","@id":"https:\/\/www.cryoport.com\/fr\/#\/schema\/person\/41e3344a83f354e30051a36b4e0a5f86","name":"smendez","image":{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/secure.gravatar.com\/avatar\/3ce9d56659c228959822d42e6e9146f3170fc590e93aa3adda9bb496df111835?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/3ce9d56659c228959822d42e6e9146f3170fc590e93aa3adda9bb496df111835?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/3ce9d56659c228959822d42e6e9146f3170fc590e93aa3adda9bb496df111835?s=96&d=mm&r=g","caption":"smendez"}}]}},"_links":{"self":[{"href":"https:\/\/www.cryoport.com\/fr\/wp-json\/wp\/v2\/posts\/26892","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.cryoport.com\/fr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.cryoport.com\/fr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.cryoport.com\/fr\/wp-json\/wp\/v2\/users\/38"}],"replies":[{"embeddable":true,"href":"https:\/\/www.cryoport.com\/fr\/wp-json\/wp\/v2\/comments?post=26892"}],"version-history":[{"count":2,"href":"https:\/\/www.cryoport.com\/fr\/wp-json\/wp\/v2\/posts\/26892\/revisions"}],"predecessor-version":[{"id":27189,"href":"https:\/\/www.cryoport.com\/fr\/wp-json\/wp\/v2\/posts\/26892\/revisions\/27189"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.cryoport.com\/fr\/wp-json\/wp\/v2\/media\/26898"}],"wp:attachment":[{"href":"https:\/\/www.cryoport.com\/fr\/wp-json\/wp\/v2\/media?parent=26892"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.cryoport.com\/fr\/wp-json\/wp\/v2\/categories?post=26892"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.cryoport.com\/fr\/wp-json\/wp\/v2\/tags?post=26892"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}